4//SEC Filing
Leheny A. Rachel 4
Accession 0001209191-23-035609
CIK 0001534133other
Filed
Jun 7, 8:00 PM ET
Accepted
Jun 8, 9:09 PM ET
Size
10.7 KB
Accession
0001209191-23-035609
Insider Transaction Report
Form 4
Leheny A. Rachel
DirectorCHIEF EXECUTIVE OFFICER10% Owner
Transactions
- Purchase
Common Stock
2023-06-07$5.25/sh+1,000$5,248→ 8,000 total - Purchase
Common Stock
2023-06-06$5.13/sh+1,000$5,129→ 7,000 total
Holdings
- 1,000(indirect: By Spouse)
Common Stock
- 316,109(indirect: By LLC)
Common Stock
- 66,228(indirect: By LLC)
Common Stock
- 356,989(indirect: By LLC)
Common Stock
Footnotes (3)
- [F1]The weighted average purchase price for the transaction reported was $5.1287, and the range of prices were between $4.48 and $5.24. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares purchased at each separate price will be provided.
- [F2]The weighted average purchase price for the transaction reported was $5.2478, and the range of prices were between $5.225 and $5.25. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares purchased at each separate price will be provided.
- [F3]The Reporting Person, a co-founder and managing director of Valence Investments SPV IV, LLC ("Valence IV"), Valence Investments SPV V, LLC ("Valence V") and Valence Investments SPV VI, LLC (Valence VI), may be deemed to beneficially own the securities held by Valence IV, Valence V and Valence VI (the "Valence Securities"). The Reporting Person disclaims beneficial ownership of the Valence Securities except to the extent of her pecuniary interest therein.
Documents
Issuer
CalciMedica, Inc.
CIK 0001534133
Entity typeother
Related Parties
1- filerCIK 0001484729
Filing Metadata
- Form type
- 4
- Filed
- Jun 7, 8:00 PM ET
- Accepted
- Jun 8, 9:09 PM ET
- Size
- 10.7 KB